The first study has been undertaken to determine underlying biological mechanisms that promote functional recovery of the blood-brain barrier after blast injury, demonstrating that treatment with the glucocorticoid, dexamethasone, after primary blast injury promotes rapid recovery of an in vitro model of the BBB. These findings may also help improve outcomes in brain-injured soldiers and civilians, reducing the length of their mandatory rest periods before returning to duty.